Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

When will cost effectiveness ever be acceptable in US healthcare?

David Williams
Policy
May 24, 2010
Share
Tweet
Share

Cancer. The Big C. No one wants money to stand in the way of curing a patient.

But real life is messier. Many new treatments for cancer are pricey yet provide only marginal gains over existing therapies in life expectancy and/or quality of life. Forty thousand dollars for a cure is not a real dilemma for policymakers — the same spend for an extra six weeks of life is another story.

In the United States we still pretend cost effectiveness doesn’t matter, even though cost is frequently taken into account implicitly and secretly. Europe in particular has moved past that point, and takes cost effectiveness into consideration in coverage and reimbursement policies explicitly. We’re slowly moving in that direction in the US, too. Call it rationing if you want; as long as it’s understood that BMWs and mansions are rationed, too.

As cost becomes more important, payers, policymakers and physicians need a robust body of research as a basis for decision making. The Tufts Medical Center Cost-Effectiveness Analysis Registry, maintained by the Center for the Evaluation of Value and Risk in Health (CEVR), catalogs over 2000 cost-effective analyses that have been published in the peer-reviewed literature since the mid-1970s. In a recent paper in the Journal of the National Cancer Institute, entitled, When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology, CEVR director Peter J. Neumann, ScD and others review 242 cancer-related cost effectiveness papers.

Neumann has been working for years to encourage improvement in cost-effectiveness research. Ten years ago he published a paper examining the quality of oncology-related cancer research. This new paper examines how far things have come since then.

…[A]dherence to recommended methods for conducting and reporting [Cost Effectiveness Analysis] results (e.g., applying a societal perspective, discounting both costs and [Quality Adjusted Life Years], providing a clear presentation of the intervention, comparator and the target population) was high and has somewhat improved over time. During 2002-2007, almost all studies clearly presented the relevant intervention, the comparator, and the target population. The proportion of studies that correctly calculated [Incremental Cost-Effectiveness Ratios] increased from 48% before 1998 to 84% after 2001. Most studies performed a sensitivity analysis to explore uncertainties in cost-effectiveness results, and the proportion of studies that presented a probabilistic sensitivity analysis increased from zero during 1976–1997 to 44% during 2002–2007.

As a member of CEVR’s Executive Advisory Board, I am encouraged by the findings of this study. As cost-effectiveness discussions become socially acceptable in the US and as the government steps up support for cost-effectiveness research, it’s worth noting that we’re not starting from scratch. There’s still plenty of room for improvement, but CEVR and others have laid a solid foundation.

Those who oppose taking cost-effectiveness into account on ideological grounds should be aware that even oncologists care about treatment costs.

David E. Williams is co-founder of MedPharma Partners and blogs at the Health Business Blog.

Submit a guest post and be heard.

Prev

Voluntary simplicity can ease the stress of American life

May 24, 2010 Kevin 10
…
Next

Primary care innovation needs more than money

May 25, 2010 Kevin 7
…

Tagged as: Public Health & Policy

Post navigation

< Previous Post
Voluntary simplicity can ease the stress of American life
Next Post >
Primary care innovation needs more than money

ADVERTISEMENT

More by David Williams

  • The dialysis industry is a microcosm of what ails the health care system

    David Williams
  • Should patients be responsible for physician handwashing?

    David Williams
  • a desk with keyboard and ipad with the kevinmd logo

    The state of online doctor ratings: It’s still early

    David Williams

More in Policy

  • Unused IV catheters cost U.S. hospitals billions

    Piyush Pillarisetti
  • Why your health care dashboard isn’t working and how to fix it

    Dave Cummings, RN
  • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

    Robert E. White, Jr. & The Doctors Company
  • How new loan caps could destroy diversity in medical education

    Caleb Andrus-Gazyeva
  • Why transplant equity requires more than access

    Zamra Amjid, DHSc, MHA
  • Ideology, not evidence, fuels the anti-trans agenda

    Andie Riffer, PhD and Shawn E. Parra, LCSW, MSW
  • Most Popular

  • Past Week

    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • A doctor’s guide to preparing for your death

      Joseph Pepe, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
  • Recent Posts

    • A doctor’s guide to preparing for your death

      Joseph Pepe, MD | Physician
    • Coconut oil’s role in Alzheimer’s and depression

      Marc Arginteanu, MD | Conditions
    • How policy and stigma block addiction treatment

      Mariana Ndrio, MD | Physician
    • Unused IV catheters cost U.S. hospitals billions

      Piyush Pillarisetti | Policy
    • Why U.S. universities should adopt a standard pre-med major [PODCAST]

      The Podcast by KevinMD | Podcast
    • Ancient health secrets for modern life

      Larry Kaskel, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 10 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • A doctor’s guide to preparing for your death

      Joseph Pepe, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
  • Recent Posts

    • A doctor’s guide to preparing for your death

      Joseph Pepe, MD | Physician
    • Coconut oil’s role in Alzheimer’s and depression

      Marc Arginteanu, MD | Conditions
    • How policy and stigma block addiction treatment

      Mariana Ndrio, MD | Physician
    • Unused IV catheters cost U.S. hospitals billions

      Piyush Pillarisetti | Policy
    • Why U.S. universities should adopt a standard pre-med major [PODCAST]

      The Podcast by KevinMD | Podcast
    • Ancient health secrets for modern life

      Larry Kaskel, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

When will cost effectiveness ever be acceptable in US healthcare?
10 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...